Aldeyra Therapeutics
ALDX
#10254
Rank
โ‚ฌ45.44 M
Marketcap
0,75ย โ‚ฌ
Share price
14.37%
Change (1 day)
-82.12%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -โ‚ฌ18.6 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ29.08 Million, an increase over its 2024 earnings that were of -โ‚ฌ49.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ18.6 Million-36.05%
2025 -โ‚ฌ29.08 Million-40.77%
2024 -โ‚ฌ49.1 Million52.03%
2023 -โ‚ฌ32.3 Million-41.21%
2022 -โ‚ฌ54.93 Million7.67%
2021 -โ‚ฌ51.02 Million55.1%
2020 -โ‚ฌ32.9 Million-41.29%
2019 -โ‚ฌ56.02 Million58.81%
2018 -โ‚ฌ35.28 Million74.32%
2017 -โ‚ฌ20.24 Million19.56%
2016 -โ‚ฌ16.93 Million55.21%
2015 -โ‚ฌ10.91 Million142.32%
2014 -โ‚ฌ4.51 Million-137.39%
2013 โ‚ฌ12.03 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ5.17 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA